A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab

Ipilimumab is a monoclonal antibody that works as an immunotherapeutic agent through selective targeting of T cells to strengthen the response to metastatic melanoma. It is well known that this pharmaceutical agent can cause the adverse effect of colitis. We report a rare presentation of ileocolitis...

Full description

Bibliographic Details
Main Authors: Behdod Poushanchi, Hiren Vallabh, Gorman Joel Reynolds
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Case Reports in Gastrointestinal Medicine
Online Access:http://dx.doi.org/10.1155/2018/2431503
id doaj-1baa61e105a049e1870c66447b3ed8d6
record_format Article
spelling doaj-1baa61e105a049e1870c66447b3ed8d62020-11-24T23:46:31ZengHindawi LimitedCase Reports in Gastrointestinal Medicine2090-65282090-65362018-01-01201810.1155/2018/24315032431503A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and InfliximabBehdod Poushanchi0Hiren Vallabh1Gorman Joel Reynolds2Department of Medicine, West Virginia University, Morgantown, WV, USADivision of Gastroenterology, West Virginia University, Morgantown, WV, USADivision of Gastroenterology, West Virginia University, Morgantown, WV, USAIpilimumab is a monoclonal antibody that works as an immunotherapeutic agent through selective targeting of T cells to strengthen the response to metastatic melanoma. It is well known that this pharmaceutical agent can cause the adverse effect of colitis. We report a rare presentation of ileocolitis refractory to both glucocorticosteroids and infliximab with a resultant pneumatosis and perforation requiring subtotal colectomy and end ileostomy.http://dx.doi.org/10.1155/2018/2431503
collection DOAJ
language English
format Article
sources DOAJ
author Behdod Poushanchi
Hiren Vallabh
Gorman Joel Reynolds
spellingShingle Behdod Poushanchi
Hiren Vallabh
Gorman Joel Reynolds
A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
Case Reports in Gastrointestinal Medicine
author_facet Behdod Poushanchi
Hiren Vallabh
Gorman Joel Reynolds
author_sort Behdod Poushanchi
title A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
title_short A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
title_full A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
title_fullStr A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
title_full_unstemmed A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
title_sort severe case of ipilimumab-induced ileocolitis refractory to glucocorticosteroids and infliximab
publisher Hindawi Limited
series Case Reports in Gastrointestinal Medicine
issn 2090-6528
2090-6536
publishDate 2018-01-01
description Ipilimumab is a monoclonal antibody that works as an immunotherapeutic agent through selective targeting of T cells to strengthen the response to metastatic melanoma. It is well known that this pharmaceutical agent can cause the adverse effect of colitis. We report a rare presentation of ileocolitis refractory to both glucocorticosteroids and infliximab with a resultant pneumatosis and perforation requiring subtotal colectomy and end ileostomy.
url http://dx.doi.org/10.1155/2018/2431503
work_keys_str_mv AT behdodpoushanchi aseverecaseofipilimumabinducedileocolitisrefractorytoglucocorticosteroidsandinfliximab
AT hirenvallabh aseverecaseofipilimumabinducedileocolitisrefractorytoglucocorticosteroidsandinfliximab
AT gormanjoelreynolds aseverecaseofipilimumabinducedileocolitisrefractorytoglucocorticosteroidsandinfliximab
AT behdodpoushanchi severecaseofipilimumabinducedileocolitisrefractorytoglucocorticosteroidsandinfliximab
AT hirenvallabh severecaseofipilimumabinducedileocolitisrefractorytoglucocorticosteroidsandinfliximab
AT gormanjoelreynolds severecaseofipilimumabinducedileocolitisrefractorytoglucocorticosteroidsandinfliximab
_version_ 1725493363899105280